Open access
Open access
Powered by Google Translator Translator

Randomized Trial: Injectable 17-α-hydroxyprogesterone Not Effective for the Prevention of Recurrent Preterm Birth

24 Nov, 2019 | 20:59h | UTC

17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial – American Journal of Perinatology (free)

Commentary: Advice to pull a drug used to prevent premature birth sparks controversy – News Medical (free) AND Unexpected Findings in Confirmatory Trial of Preterm Birth Drug – MedPage Today (free registration required)

Related Study: A Randomized Trial of Progesterone in Women with Recurrent Miscarriages – New England Journal of Medicine (free)


Stay Updated in Your Specialty

No spam, just news.